Most Active Stories
- To Clean a Skull: Beetles, Bones, and Business
- Harping In Harmony: Beverly Inman-Ebel Previews Free CHE Concerts
- Start It Up Ep 10: Why a Good Bookkeeper Matters and Chattanooga's Filmmaking Community is on Fire
- 'The Future West' Film Team Seeks Crowdfunding for Sequel
- Douglas Tallamy: Why Home Gardening 'Transcends the Needs of the Gardener'
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 8:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.